Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long term safety and efficacy study of teriflunomide 7 mg or 14 mg in patients with relapsing-remitting multiple sclerosis
From Bugs to Brains: the gut microbiome in neurological health
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Retinyl Palmitate Supplementation Modulates T-bet and Interferon Gamma Gene Expression in Multiple Sclerosis Patients.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
Statement on a nonproprietary name adopted by the USAN Council
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Myelin in cartilaginous fish.
Useful Links
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a ...
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal function.
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.
Getting a Handle on Lymphopenia With Tecfidera
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Chemical and Biological Therapeutic Approaches to Neurological Disorders III
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Pages